Sort   by:  
 Page size 
GenomicsVaccine Delivery Platforms Affect Heterologous Protection by Hemagglutinin-Based Influenza Vaccines in Pigs
Vaccine Delivery Platforms Affect Heterologous Protection by Hemagglutinin-Based Influenza Vaccines in Pigs
PRJNA1200777 | ENA
UnknownCosts of human papillomavirus vaccine delivery in low- and middle-income countries: A systematic review.
Not available
S-EPMC10911079 | biostudies-literature
UnknownGene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
Not available
S-EPMC5131305 | biostudies-literature
UnknownMicroneedles: A New Generation Vaccine Delivery System.
Not available
S-EPMC8070939 | biostudies-literature
UnknownVaccine innovation prioritisation strategy: Findings from three country-stakeholder consultations on vaccine product innovations.
Not available
S-EPMC8657797 | biostudies-literature
UnknownCost of introducing and delivering RTS,S/AS01 malaria vaccine within the malaria vaccine implementation program.
Not available
S-EPMC9946791 | biostudies-literature
UnknownCosting oral cholera vaccine delivery using a generic oral cholera vaccine delivery planning and costing tool (CholTool).
Not available
S-EPMC8641596 | biostudies-literature
UnknownImprovement of different vaccine delivery systems for cancer therapy.
Not available
S-EPMC3024302 | biostudies-literature
ProteomicsLipid-Coated Nanoparticles Enable Enhanced Delivery of Bacterial Virulence Factors as a Potent Toxoid Vaccine Platform against Bacterial Infections
Antivirulence vaccination represents a promising strategy for infection prevention, but achieving both safety and efficacy in toxoid vaccine preparation remains a challenge. Cell membrane-based nanotoxoids offer a safe delivery platform for bacterial virulence factors in antivirulence vaccination, b...
ORGANISM(S): Bacteria Staphylococcus aureus (strain USA300) 
2025-05-09 | PXD063683 | Pride
Pore-forming toxin Antivirulence Toxoid vaccine Bacterial infection Liposome 
ProteomicsLipid-Coated Nanoparticles Enable Enhanced Delivery of Bacterial Virulence Factors as a Potent Toxoid Vaccine Platform against Bacterial Infections
Antivirulence vaccination represents a promising strategy for infection prevention, but achieving both safety and efficacy in toxoid vaccine preparation remains a challenge. Cell membrane-based nanotoxoids offer a safe delivery platform for bacterial virulence factors in antivirulence vaccination, b...
ORGANISM(S): Pseudomonas aeruginosa PA103 Bacteria 
2025-05-09 | PXD063625 | Pride
Pore-forming toxin Antivirulence Toxoid vaccine Bacterial infection Liposome 
Sort   by:  
 Page size